Cell Metabolism, ISSN 1550-4131, 12/2008, Volume 8, Issue 6, pp. 532 - 539
Glucagon-like peptide-1 (GLP-1) is an enteric hormone that stimulates insulin secretion and improves glycaemia in type 2 diabetes. Although GLP-1-based...
HUMDISEASE | SYSTEM | GLYCEMIC CONTROL | PROTEIN | GLUCAGON-LIKE PEPTIDE-1 | LINE | ENDOCRINOLOGY & METABOLISM | SMALL-INTESTINE | RECEPTOR | TASTE | SECRETION | RELEASE | CELL BIOLOGY | KATP Channels - physiology | Glucagon-Like Peptide 1 - metabolism | Calcium - metabolism | Electrophysiology | Mice, Transgenic | Glucose - pharmacology | Glucokinase - metabolism | Calcium - chemistry | Glucagon-Like Peptide 1 - secretion | Animals | Biological Transport | Glucose - metabolism | Mice | Enteroendocrine Cells - metabolism | Type 2 diabetes | Fluorescence | Glucose | Peptides | Dextrose | Tolbutamide | Short
HUMDISEASE | SYSTEM | GLYCEMIC CONTROL | PROTEIN | GLUCAGON-LIKE PEPTIDE-1 | LINE | ENDOCRINOLOGY & METABOLISM | SMALL-INTESTINE | RECEPTOR | TASTE | SECRETION | RELEASE | CELL BIOLOGY | KATP Channels - physiology | Glucagon-Like Peptide 1 - metabolism | Calcium - metabolism | Electrophysiology | Mice, Transgenic | Glucose - pharmacology | Glucokinase - metabolism | Calcium - chemistry | Glucagon-Like Peptide 1 - secretion | Animals | Biological Transport | Glucose - metabolism | Mice | Enteroendocrine Cells - metabolism | Type 2 diabetes | Fluorescence | Glucose | Peptides | Dextrose | Tolbutamide | Short
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2011, Volume 17, Issue 11, pp. 1481 - 1489
Exercise, obesity and type 2 diabetes are associated with elevated plasma concentrations of interleukin-6 (IL-6). Glucagon-like peptide-1 (GLP-1) is a hormone...
MEDICINE, RESEARCH & EXPERIMENTAL | GLP-1 | BENEFICIAL ROLE | BIOCHEMISTRY & MOLECULAR BIOLOGY | EXERCISE | CELL BIOLOGY | SKELETAL-MUSCLE | IN-VITRO | GLUCOSE-HOMEOSTASIS | HORMONE | BETA-CELL | MICE | EXPRESSION | Interleukin-6 - antagonists & inhibitors | Humans | Male | Diabetes Mellitus, Type 2 - metabolism | Glucagon-Secreting Cells - drug effects | Diet, High-Fat | Glucagon-Secreting Cells - metabolism | Female | Enteroendocrine Cells - metabolism | Insulin Secretion | Interleukin-6 - metabolism | Physical Conditioning, Animal | Disease Models, Animal | Glucose Tolerance Test | Glucagon-Like Peptide 1 - metabolism | Interleukin-6 - genetics | Mice, Inbred C57BL | Cells, Cultured | Mice, Transgenic | Insulin - metabolism | Animals | Diabetes Mellitus, Type 2 - physiopathology | Interleukin-6 - pharmacology | Signal Transduction - drug effects | Signal Transduction - physiology | Mice | Blood Glucose - metabolism | Enteroendocrine Cells - drug effects | Type 2 diabetes | Care and treatment | Physiological aspects | Genetic aspects | Research | Insulin | Interleukin-6 | Peptides | Cellular biology | Pharmacology | Diabetes | Pancreas | Endocrinology
MEDICINE, RESEARCH & EXPERIMENTAL | GLP-1 | BENEFICIAL ROLE | BIOCHEMISTRY & MOLECULAR BIOLOGY | EXERCISE | CELL BIOLOGY | SKELETAL-MUSCLE | IN-VITRO | GLUCOSE-HOMEOSTASIS | HORMONE | BETA-CELL | MICE | EXPRESSION | Interleukin-6 - antagonists & inhibitors | Humans | Male | Diabetes Mellitus, Type 2 - metabolism | Glucagon-Secreting Cells - drug effects | Diet, High-Fat | Glucagon-Secreting Cells - metabolism | Female | Enteroendocrine Cells - metabolism | Insulin Secretion | Interleukin-6 - metabolism | Physical Conditioning, Animal | Disease Models, Animal | Glucose Tolerance Test | Glucagon-Like Peptide 1 - metabolism | Interleukin-6 - genetics | Mice, Inbred C57BL | Cells, Cultured | Mice, Transgenic | Insulin - metabolism | Animals | Diabetes Mellitus, Type 2 - physiopathology | Interleukin-6 - pharmacology | Signal Transduction - drug effects | Signal Transduction - physiology | Mice | Blood Glucose - metabolism | Enteroendocrine Cells - drug effects | Type 2 diabetes | Care and treatment | Physiological aspects | Genetic aspects | Research | Insulin | Interleukin-6 | Peptides | Cellular biology | Pharmacology | Diabetes | Pancreas | Endocrinology
Journal Article
Cell Reports, ISSN 2211-1247, 11/2014, Volume 9, Issue 4, pp. 1202 - 1208
It has long been speculated that metabolites, produced by gut microbiota, influence host metabolism in health and diseases. Here, we reveal that indole,...
TRYPTOPHAN | COLONIC BACTERIA | LIRAGLUTIDE | CHAIN FATTY-ACIDS | MOUSE | LINE | GUT MICROBIOTA | RECEPTOR AGONIST | PEPTIDE-1 SECRETION | SIGNAL INDOLE | CELL BIOLOGY | Colon - cytology | Calcium - metabolism | Cells, Cultured | Ions | Adenosine Triphosphate - biosynthesis | Enteroendocrine Cells - secretion | Glucagon-Like Peptide 1 - secretion | Animals | Potassium Channels, Voltage-Gated - metabolism | Adenosine Triphosphate - metabolism | Potassium Chloride - pharmacology | Incretins - secretion | Indoles - pharmacology | Mice | Adenosine Diphosphate - metabolism | NADP - metabolism | Enteroendocrine Cells - drug effects | Action Potentials - drug effects
TRYPTOPHAN | COLONIC BACTERIA | LIRAGLUTIDE | CHAIN FATTY-ACIDS | MOUSE | LINE | GUT MICROBIOTA | RECEPTOR AGONIST | PEPTIDE-1 SECRETION | SIGNAL INDOLE | CELL BIOLOGY | Colon - cytology | Calcium - metabolism | Cells, Cultured | Ions | Adenosine Triphosphate - biosynthesis | Enteroendocrine Cells - secretion | Glucagon-Like Peptide 1 - secretion | Animals | Potassium Channels, Voltage-Gated - metabolism | Adenosine Triphosphate - metabolism | Potassium Chloride - pharmacology | Incretins - secretion | Indoles - pharmacology | Mice | Adenosine Diphosphate - metabolism | NADP - metabolism | Enteroendocrine Cells - drug effects | Action Potentials - drug effects
Journal Article
Diabetologia, ISSN 0012-186X, 8/2015, Volume 58, Issue 8, pp. 1887 - 1897
Glucagon-like peptide (GLP-1), an intestinal incretin produced in L cells through proglucagon processing, is released in response to meal intake. The...
Blood glucose | GLP-1 | Medicine & Public Health | Human Physiology | Intestine | Metabolic Diseases | mTOR | Internal Medicine | Enteroendocrine L cells | Neurogenin 3 | MAMMALIAN TARGET | RAPAMYCIN | PROGLUCAGON GENE-EXPRESSION | RAT MODEL | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE | IN-VIVO | ENDOCRINOLOGY & METABOLISM | PEPTIDASE-4 INHIBITOR SITAGLIPTIN | ENDOCRINE-CELLS | MOLECULAR-MECHANISMS | Intestines - drug effects | Leucine - pharmacology | Glucagon-Like Peptide 1 - metabolism | TOR Serine-Threonine Kinases - metabolism | Down-Regulation | Mice, Inbred C57BL | Male | Intestines - metabolism | Sirolimus - pharmacology | Mice, Knockout | Animals | Diet, High-Fat | Mice | Enteroendocrine Cells - metabolism | Fasting - metabolism | Diabetes Mellitus, Experimental - metabolism | Enteroendocrine Cells - drug effects | Proglucagon - metabolism | Physiological aspects | Enzymes | Sensors | Blood sugar | Cells
Blood glucose | GLP-1 | Medicine & Public Health | Human Physiology | Intestine | Metabolic Diseases | mTOR | Internal Medicine | Enteroendocrine L cells | Neurogenin 3 | MAMMALIAN TARGET | RAPAMYCIN | PROGLUCAGON GENE-EXPRESSION | RAT MODEL | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE | IN-VIVO | ENDOCRINOLOGY & METABOLISM | PEPTIDASE-4 INHIBITOR SITAGLIPTIN | ENDOCRINE-CELLS | MOLECULAR-MECHANISMS | Intestines - drug effects | Leucine - pharmacology | Glucagon-Like Peptide 1 - metabolism | TOR Serine-Threonine Kinases - metabolism | Down-Regulation | Mice, Inbred C57BL | Male | Intestines - metabolism | Sirolimus - pharmacology | Mice, Knockout | Animals | Diet, High-Fat | Mice | Enteroendocrine Cells - metabolism | Fasting - metabolism | Diabetes Mellitus, Experimental - metabolism | Enteroendocrine Cells - drug effects | Proglucagon - metabolism | Physiological aspects | Enzymes | Sensors | Blood sugar | Cells
Journal Article
Frontiers in Bioscience - Landmark, ISSN 1093-9946, 03/2018, Volume 23, Issue 9, pp. 1740 - 1753
Enteroendocrine L cells are open-type enteroendocrine cells that play an important role in amino acid sensing. They detect amino acids by a number of membrane...
Disease | Electrical activity | Amino acid sensing | Intestinal enteroendocrine cells | L cells | Review | Hormone secretion | SIGNALING PATHWAYS | FOOD-INTAKE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROELECTRODE ARRAYS | CELL BIOLOGY | TYPE-2 DIABETIC-PATIENTS | GLUCAGON-LIKE PEPTIDE-1 | LINE STC-1 | PROTEIN-COUPLED RECEPTOR | COLORECTAL-CANCER | GASTROINTESTINAL HORMONES | GENE-TRANSCRIPTION | Humans | Receptors, Cell Surface - metabolism | Diabetes Mellitus, Type 2 - metabolism | Obesity - metabolism | Amino Acids - metabolism | Animals | Signal Transduction - drug effects | Gastrointestinal Hormones - metabolism | Enteroendocrine Cells - physiology | Signal Transduction - physiology | Enteroendocrine Cells - metabolism | Glutamine - pharmacology | Enteroendocrine Cells - drug effects
Disease | Electrical activity | Amino acid sensing | Intestinal enteroendocrine cells | L cells | Review | Hormone secretion | SIGNALING PATHWAYS | FOOD-INTAKE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MICROELECTRODE ARRAYS | CELL BIOLOGY | TYPE-2 DIABETIC-PATIENTS | GLUCAGON-LIKE PEPTIDE-1 | LINE STC-1 | PROTEIN-COUPLED RECEPTOR | COLORECTAL-CANCER | GASTROINTESTINAL HORMONES | GENE-TRANSCRIPTION | Humans | Receptors, Cell Surface - metabolism | Diabetes Mellitus, Type 2 - metabolism | Obesity - metabolism | Amino Acids - metabolism | Animals | Signal Transduction - drug effects | Gastrointestinal Hormones - metabolism | Enteroendocrine Cells - physiology | Signal Transduction - physiology | Enteroendocrine Cells - metabolism | Glutamine - pharmacology | Enteroendocrine Cells - drug effects
Journal Article
Molecular and Cellular Endocrinology, ISSN 0303-7207, 11/2015, Volume 416, Issue C, pp. 9 - 18
Glucagon-like peptide (GLP-1), an intestinal incretin produced in L-cells and released in response to meal intake, functions to promote insulin secretion and...
Incretin | GLP-1 | Enteroendocrine L cells | Ghrelin | GHSR1a | mTORC1 | MTORC1 | GLYCEMIC CONTROL | HUMANS | INSULIN-RELEASE | CELL BIOLOGY | GLUCAGON-LIKE PEPTIDE-1 | GENE | GLUCOSE-METABOLISM | BIOLOGY | ENDOCRINOLOGY & METABOLISM | DEGRADATION | IMPROVES | SECRETION | Glucagon-Like Peptide 1 - metabolism | TOR Serine-Threonine Kinases - metabolism | Mice, Inbred C57BL | Ileum - metabolism | Incretins - metabolism | Ghrelin - pharmacology | Male | Oligopeptides - metabolism | Receptors, Ghrelin - genetics | Mice, Knockout | Ghrelin - metabolism | Insulin - metabolism | Animals | Cell Line, Tumor | Mice | Enteroendocrine Cells - metabolism | Blood Glucose - metabolism | Enteroendocrine Cells - drug effects | Insulin Secretion | Glucagon | Dextrose | Glucose
Incretin | GLP-1 | Enteroendocrine L cells | Ghrelin | GHSR1a | mTORC1 | MTORC1 | GLYCEMIC CONTROL | HUMANS | INSULIN-RELEASE | CELL BIOLOGY | GLUCAGON-LIKE PEPTIDE-1 | GENE | GLUCOSE-METABOLISM | BIOLOGY | ENDOCRINOLOGY & METABOLISM | DEGRADATION | IMPROVES | SECRETION | Glucagon-Like Peptide 1 - metabolism | TOR Serine-Threonine Kinases - metabolism | Mice, Inbred C57BL | Ileum - metabolism | Incretins - metabolism | Ghrelin - pharmacology | Male | Oligopeptides - metabolism | Receptors, Ghrelin - genetics | Mice, Knockout | Ghrelin - metabolism | Insulin - metabolism | Animals | Cell Line, Tumor | Mice | Enteroendocrine Cells - metabolism | Blood Glucose - metabolism | Enteroendocrine Cells - drug effects | Insulin Secretion | Glucagon | Dextrose | Glucose
Journal Article
Diabetologia, ISSN 0012-186X, 2/2018, Volume 61, Issue 2, pp. 284 - 294
Enteroendocrine K and L cells are pivotal in regulating appetite and glucose homeostasis. Knowledge of their distribution in humans is sparse and it is unknown...
Immunohistochemistry | Type 2 diabetes | Chromogranin A | Glucose-dependent insulinotropic polypeptide | Human Physiology | Metabolic Diseases | Double-balloon enteroscopy | Internal Medicine | Peptide YY | mRNA expression | Prohormone convertase | Glucagon-like peptide-1 | Medicine & Public Health | Enteroendocrine cells | ChromograninA | FOOD-INTAKE | CHROMOGRANIN | SMALL-INTESTINE | GLUCOSE | ENDOCRINOLOGY & METABOLISM | DEPENDENT INSULINOTROPIC POLYPEPTIDE | SECRETION | GASTRIC-INHIBITORY POLYPEPTIDE | HUMAN GASTROINTESTINAL-TRACT | ENDOCRINE-CELLS | Appetite | Glucagon | Diabetes mellitus | Mucosa | Homeostasis | L cells | GIP protein | Gene expression | Small intestine | Biopsy | Large intestine | Prohormone convertase 2 | Prohormone convertase 1 | Diabetes | Colon | Glucagon-like peptide 1
Immunohistochemistry | Type 2 diabetes | Chromogranin A | Glucose-dependent insulinotropic polypeptide | Human Physiology | Metabolic Diseases | Double-balloon enteroscopy | Internal Medicine | Peptide YY | mRNA expression | Prohormone convertase | Glucagon-like peptide-1 | Medicine & Public Health | Enteroendocrine cells | ChromograninA | FOOD-INTAKE | CHROMOGRANIN | SMALL-INTESTINE | GLUCOSE | ENDOCRINOLOGY & METABOLISM | DEPENDENT INSULINOTROPIC POLYPEPTIDE | SECRETION | GASTRIC-INHIBITORY POLYPEPTIDE | HUMAN GASTROINTESTINAL-TRACT | ENDOCRINE-CELLS | Appetite | Glucagon | Diabetes mellitus | Mucosa | Homeostasis | L cells | GIP protein | Gene expression | Small intestine | Biopsy | Large intestine | Prohormone convertase 2 | Prohormone convertase 1 | Diabetes | Colon | Glucagon-like peptide 1
Journal Article
Peptides, ISSN 0196-9781, 03/2016, Volume 77, pp. 21 - 27
Glucagon-like peptide-1 (GLP-1) acts as a satiety signal and enhances insulin release. This study examined how GLP-1 production from intestinal L-cells is...
Enteroendocrine | GLP-1 | L-cell | High fat diet | NUMBER | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | INTESTINE | GLUCOSE | HELIX TRANSCRIPTION FACTORS | ENTEROENDOCRINE CELLS | PHARMACOLOGY & PHARMACY | SECRETION | DIFFERENTIATION | EXPRESSION | Gene Expression | Animals | Glucagon-Like Peptide 1 - metabolism | Mice, Inbred C57BL | Cells, Cultured | Diet, High-Fat - adverse effects | Enteroendocrine Cells - physiology | Male | Primary Cell Culture | Glucagon-Like Peptide 1 - genetics | Glucagon-Like Peptide 1 - secretion | Glucagon | Diets | Reduction | Nutrients | Mathematical models | Mice | Gene expression | Secretions | Insulin
Enteroendocrine | GLP-1 | L-cell | High fat diet | NUMBER | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | INTESTINE | GLUCOSE | HELIX TRANSCRIPTION FACTORS | ENTEROENDOCRINE CELLS | PHARMACOLOGY & PHARMACY | SECRETION | DIFFERENTIATION | EXPRESSION | Gene Expression | Animals | Glucagon-Like Peptide 1 - metabolism | Mice, Inbred C57BL | Cells, Cultured | Diet, High-Fat - adverse effects | Enteroendocrine Cells - physiology | Male | Primary Cell Culture | Glucagon-Like Peptide 1 - genetics | Glucagon-Like Peptide 1 - secretion | Glucagon | Diets | Reduction | Nutrients | Mathematical models | Mice | Gene expression | Secretions | Insulin
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e65696
Background and Aims: Roux-en-Y gastric bypass (RYGB) leads to a rapid remission of type 2 diabetes mellitus (T2DM), but the underlying mode of action remains...
DIABETES-MELLITUS | GUT HORMONES | JEJUNOILEAL BYPASS | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE-METABOLISM | BILIOPANCREATIC DIVERSION | MULTIDISCIPLINARY SCIENCES | WEIGHT-LOSS | BARIATRIC SURGERY | MORBID-OBESITY | INTESTINAL EPITHELIAL PROLIFERATION | Hypertrophy - etiology | Glucagon-Like Peptide 1 - metabolism | Peptide YY - metabolism | Rats, Wistar | Gastric Bypass - adverse effects | Rats | Male | Enteroendocrine Cells - cytology | Glucagon-Like Peptide 1 - genetics | Hypertrophy - physiopathology | Mucous Membrane - metabolism | Animals | Proglucagon - genetics | Enteroendocrine Cells - metabolism | Peptide YY - genetics | Proglucagon - metabolism | Type 2 diabetes | Glucagon | RNA | Body weight | Gastric bypass | Gene expression | Hypertrophy | Transcription | Mucosa | Adaptability | Hormones | Small intestine | Cell density | Dietary restrictions | Food availability | Surgery | Rodents | Remission | Digestive tract | Glucagon-like peptide 1 | Food | Obesity | Digestive system | Diabetes mellitus | Mode of action | Cell number | Gastrointestinal surgery
DIABETES-MELLITUS | GUT HORMONES | JEJUNOILEAL BYPASS | GLUCAGON-LIKE PEPTIDE-1 | GLUCOSE-METABOLISM | BILIOPANCREATIC DIVERSION | MULTIDISCIPLINARY SCIENCES | WEIGHT-LOSS | BARIATRIC SURGERY | MORBID-OBESITY | INTESTINAL EPITHELIAL PROLIFERATION | Hypertrophy - etiology | Glucagon-Like Peptide 1 - metabolism | Peptide YY - metabolism | Rats, Wistar | Gastric Bypass - adverse effects | Rats | Male | Enteroendocrine Cells - cytology | Glucagon-Like Peptide 1 - genetics | Hypertrophy - physiopathology | Mucous Membrane - metabolism | Animals | Proglucagon - genetics | Enteroendocrine Cells - metabolism | Peptide YY - genetics | Proglucagon - metabolism | Type 2 diabetes | Glucagon | RNA | Body weight | Gastric bypass | Gene expression | Hypertrophy | Transcription | Mucosa | Adaptability | Hormones | Small intestine | Cell density | Dietary restrictions | Food availability | Surgery | Rodents | Remission | Digestive tract | Glucagon-like peptide 1 | Food | Obesity | Digestive system | Diabetes mellitus | Mode of action | Cell number | Gastrointestinal surgery
Journal Article
Nature Communications, ISSN 2041-1723, 2015, Volume 6, Issue 1, p. 7629
Bile acids are signalling molecules, which activate the transmembrane receptor TGR5 and the nuclear receptor FXR. BA sequestrants (BAS) complex bile acids in...
GLP-1 SECRETION | FXR | BILE-ACID RECEPTORS | GLUCOSE-HOMEOSTASIS | OBESITY | MULTIDISCIPLINARY SCIENCES | RAT SMALL-INTESTINE | MICE | TYPE-2 DIABETES-MELLITUS | METABOLIC-RATE | EXPRESSION | Colon - cytology | Intestinal Mucosa - metabolism | Sequestering Agents - pharmacology | Humans | Ileum - metabolism | RNA, Messenger - metabolism | Colesevelam Hydrochloride - pharmacology | Obesity - genetics | Glucagon-Like Peptide 1 - genetics | Jejunum - metabolism | Insulin-Secreting Cells - metabolism | Proglucagon - drug effects | Diet, High-Fat | Jejunum - cytology | Enteroendocrine Cells - metabolism | Ileum - cytology | Proglucagon - metabolism | Insulin Secretion | Glucagon-Like Peptide 1 - metabolism | Signal Transduction | Bile Acids and Salts - metabolism | Nuclear Proteins - metabolism | Receptors, Cytoplasmic and Nuclear - genetics | Colon - metabolism | Mice, Knockout | Obesity - metabolism | Transcription Factors - metabolism | Insulin - metabolism | Animals | Glycolysis | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism | Mice, Obese | Mice | Proglucagon - genetics | Receptors, G-Protein-Coupled - genetics | Blood Glucose - metabolism | Anticholesteremic Agents - pharmacology | Intestines - cytology | Carbohydrates | Glucose | Gene expression | Insulin | Cell and Molecular Biology | Endokrinologi och diabetes | Multidisciplinary Sciences | Cell- och molekylärbiologi | Endocrinology and Diabetes
GLP-1 SECRETION | FXR | BILE-ACID RECEPTORS | GLUCOSE-HOMEOSTASIS | OBESITY | MULTIDISCIPLINARY SCIENCES | RAT SMALL-INTESTINE | MICE | TYPE-2 DIABETES-MELLITUS | METABOLIC-RATE | EXPRESSION | Colon - cytology | Intestinal Mucosa - metabolism | Sequestering Agents - pharmacology | Humans | Ileum - metabolism | RNA, Messenger - metabolism | Colesevelam Hydrochloride - pharmacology | Obesity - genetics | Glucagon-Like Peptide 1 - genetics | Jejunum - metabolism | Insulin-Secreting Cells - metabolism | Proglucagon - drug effects | Diet, High-Fat | Jejunum - cytology | Enteroendocrine Cells - metabolism | Ileum - cytology | Proglucagon - metabolism | Insulin Secretion | Glucagon-Like Peptide 1 - metabolism | Signal Transduction | Bile Acids and Salts - metabolism | Nuclear Proteins - metabolism | Receptors, Cytoplasmic and Nuclear - genetics | Colon - metabolism | Mice, Knockout | Obesity - metabolism | Transcription Factors - metabolism | Insulin - metabolism | Animals | Glycolysis | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism | Mice, Obese | Mice | Proglucagon - genetics | Receptors, G-Protein-Coupled - genetics | Blood Glucose - metabolism | Anticholesteremic Agents - pharmacology | Intestines - cytology | Carbohydrates | Glucose | Gene expression | Insulin | Cell and Molecular Biology | Endokrinologi och diabetes | Multidisciplinary Sciences | Cell- och molekylärbiologi | Endocrinology and Diabetes
Journal Article
11.
Full Text
Lipid derivatives activate GPR119 and trigger GLP-1 secretion in primary murine L-cells
Peptides, ISSN 0196-9781, 03/2016, Volume 77, pp. 16 - 20
Glucagon-like peptide-1 (GLP-1) is an incretin hormone derived from proglucagon, which is released from intestinal L-cells and increases insulin secretion in a...
Incretin | GPR119 | GLP-1 | PATHWAYS | GLYCEMIC CONTROL | BIOCHEMISTRY & MOLECULAR BIOLOGY | OLEOYLETHANOLAMIDE | RELEASE | AGONISTS | DISCOVERY | G-PROTEIN-COUPLED-RECEPTOR-119 | GLUCAGON-LIKE PEPTIDE-1 | DEPENDENT INSULIN-SECRETION | PROTEIN-COUPLED RECEPTOR | PHARMACOLOGY & PHARMACY | Receptors, G-Protein-Coupled - metabolism | Cells, Cultured | Male | Mice, Transgenic | Olive Oil - administration & dosage | Corn Oil - pharmacology | Enteroendocrine Cells - secretion | Glucagon-Like Peptide 1 - secretion | Olive Oil - pharmacology | Animals | Female | Primary Cell Culture | Enteroendocrine Cells - drug effects | Cyclic AMP - metabolism | Second Messenger Systems | Cyclic adenylic acid | Sensors | Intestines | Fretting | Lipids | Ligands | Mice | Derivatives | Secretions | Culture | Fsk, forskolin | WT, wildtype | KO, knockout | GLP-1, glucagon-like peptide-1 | IBMX, 3-isobutyl-1-methylxanthine | 2-OG, 2-oleoylglycerol | OEA, oleoylethanolamide | PPAR, peroxisome-proliferator-activated receptor
Incretin | GPR119 | GLP-1 | PATHWAYS | GLYCEMIC CONTROL | BIOCHEMISTRY & MOLECULAR BIOLOGY | OLEOYLETHANOLAMIDE | RELEASE | AGONISTS | DISCOVERY | G-PROTEIN-COUPLED-RECEPTOR-119 | GLUCAGON-LIKE PEPTIDE-1 | DEPENDENT INSULIN-SECRETION | PROTEIN-COUPLED RECEPTOR | PHARMACOLOGY & PHARMACY | Receptors, G-Protein-Coupled - metabolism | Cells, Cultured | Male | Mice, Transgenic | Olive Oil - administration & dosage | Corn Oil - pharmacology | Enteroendocrine Cells - secretion | Glucagon-Like Peptide 1 - secretion | Olive Oil - pharmacology | Animals | Female | Primary Cell Culture | Enteroendocrine Cells - drug effects | Cyclic AMP - metabolism | Second Messenger Systems | Cyclic adenylic acid | Sensors | Intestines | Fretting | Lipids | Ligands | Mice | Derivatives | Secretions | Culture | Fsk, forskolin | WT, wildtype | KO, knockout | GLP-1, glucagon-like peptide-1 | IBMX, 3-isobutyl-1-methylxanthine | 2-OG, 2-oleoylglycerol | OEA, oleoylethanolamide | PPAR, peroxisome-proliferator-activated receptor
Journal Article
Peptides, ISSN 0196-9781, 03/2016, Volume 77, pp. 9 - 15
Glucagon like peptide-1 is an insulinotropic hormone released from intestinal L-cells in response to food ingestion. Here, we investigated mechanisms...
Enteroendocrine | GLP-1 | L-cell | Peptones | PROTEIN | INCRETIN HORMONE | STIMULATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLUTAG CELLS | HYDROLYSATE | GLUCAGON-LIKE PEPTIDE-1 | CALCIUM-SENSING RECEPTOR | AMINO-ACIDS | ENDOCRINOLOGY & METABOLISM | PHARMACOLOGY & PHARMACY | SECRETION | CA2+-SENSING RECEPTOR | Animals | Peptones - physiology | Tissue Culture Techniques | Enteroendocrine Cells - physiology | Mice, Transgenic | Peptones - pharmacology | Calcium Channels, L-Type - metabolism | Transient Receptor Potential Channels - metabolism | Enteroendocrine Cells - drug effects | Calcium Signaling | Glucagon-Like Peptide 1 - secretion | Type 2 diabetes | Enzymes | Protein hydrolysates | Receptors | Calcium | Pathways | Inhibition | Detection | Channels | Meat
Enteroendocrine | GLP-1 | L-cell | Peptones | PROTEIN | INCRETIN HORMONE | STIMULATE | BIOCHEMISTRY & MOLECULAR BIOLOGY | GLUTAG CELLS | HYDROLYSATE | GLUCAGON-LIKE PEPTIDE-1 | CALCIUM-SENSING RECEPTOR | AMINO-ACIDS | ENDOCRINOLOGY & METABOLISM | PHARMACOLOGY & PHARMACY | SECRETION | CA2+-SENSING RECEPTOR | Animals | Peptones - physiology | Tissue Culture Techniques | Enteroendocrine Cells - physiology | Mice, Transgenic | Peptones - pharmacology | Calcium Channels, L-Type - metabolism | Transient Receptor Potential Channels - metabolism | Enteroendocrine Cells - drug effects | Calcium Signaling | Glucagon-Like Peptide 1 - secretion | Type 2 diabetes | Enzymes | Protein hydrolysates | Receptors | Calcium | Pathways | Inhibition | Detection | Channels | Meat
Journal Article
Cell Reports, ISSN 2211-1247, 10/2017, Volume 21, Issue 5, pp. 1160 - 1168
Glucagon-like peptide 1 (GLP-1) is a hormone released from enteroendocrine L cells. Although first described as a glucoregulatory incretin hormone, GLP-1 also...
enteroendocrine cells | lipopolysaccharides | intestinal ischemia | inflammation | glucagon-like peptide 1 | TLR4 | gut injury | MORTALITY | PHYSIOLOGY | INHIBITION | GLUCAGON-LIKE PEPTIDE-1 | MECHANISM | RECEPTOR AGONISTS | INFLAMMATION | INSULIN-SECRETION | LIPOPOLYSACCHARIDE | MICE | CELL BIOLOGY | Life Sciences | Food and Nutrition
enteroendocrine cells | lipopolysaccharides | intestinal ischemia | inflammation | glucagon-like peptide 1 | TLR4 | gut injury | MORTALITY | PHYSIOLOGY | INHIBITION | GLUCAGON-LIKE PEPTIDE-1 | MECHANISM | RECEPTOR AGONISTS | INFLAMMATION | INSULIN-SECRETION | LIPOPOLYSACCHARIDE | MICE | CELL BIOLOGY | Life Sciences | Food and Nutrition
Journal Article